Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03340376
Brief Title: Doxorubicin Alone Versus Atezolizumab Alone Versus Doxorubicin and Atezolizumab in Recurrent Cervical Cancer

First Submitted : April 5, 2017
First Submitted that Met QC Criteria : November 8, 2017
First Posted : November 13, 2017

Last Update Submitted that Met QC Criteria : May 18, 2018
Last Update Posted : May 22, 2018